An efficient method for recombinant production of human alpha synuclein in<i>Escherichia coli</i>using thioredoxin as a fusion partner

Saffari, Babak; Amininasab, Mehriar; Sheikhi, Sara; Davoodi, Jamshid

doi:10.1080/10826068.2020.1734938

Cited by 2 publications

(1 citation statement)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Expression and purification of recombinant hαS protein was achieved, as described previously. 113 hαS Sample Preparation and Incubation. hαS was dissolved in PBS (20 mM disodium hydrogen phosphate, 100 mM sodium chloride, and 0.05% w/V of sodium azide at pH 7.5) with a final concentration of 1 mg/mL (∼70 μM).…”

Section: ■ Results and Discussionmentioning

confidence: 99%

Crocin Inhibits the Fibrillation of Human α-synuclein and Disassembles Mature Fibrils: Experimental Findings and Mechanistic Insights from Molecular Dynamics Simulation

Saffari

Amininasab

2021

ACS Chem. Neurosci.

Self Cite

View full text Add to dashboard Cite

The aggregation of human alpha-synuclein (hαS) is pivotally implicated in the development of most types of synucleinopathies. Molecules that can inhibit or reverse the aggregation process of amyloidogenic proteins have potential therapeutic value. The anti-aggregating activity of multiple carotenoid compounds has been reported over the past decades against a growing list of amyloidogenic polypeptides. Here, we aimed to determine whether crocin, the main carotenoid glycoside component of saffron, would inhibit hαS aggregation or could disassemble its preformed fibrils. By employing a series of biochemical and biophysical techniques, crocin was exhibited to inhibit hαS fibrillation in a dose-dependent fashion by stabilizing very early aggregation intermediates in off-pathway non-toxic conformations with little β-sheet content. We also observed that crocin at high concentrations could efficiently destabilize mature fibrils and disassemble them into seeding-incompetent intermediates by altering their β-sheet conformation and reshaping their structure. Our atomistic molecular dynamics (MD) simulations demonstrated that crocin molecules bind to both the non amyloid-β component (NAC) region and C-terminal domain of hαS. These interactions could thereby stabilize the autoinhibitory conformation of the protein and prevent it from adopting aggregation-prone structures. MD simulations further suggested that ligand molecules prefer to reside longitudinally along the fibril axis onto the edges of the inter-protofilament interface where they establish hydrogen and hydrophobic bonds with steric zipper stabilizing residues. These interactions turned out to destabilize hαS fibrils by altering the interstrand twist angles, increasing the rigidity of the fibril core, and elevating its radius of gyration. Our findings suggest the potential pharmaceutical implication of crocin in synucleinopathies.

show abstract

Section: ■ Results and Discussionmentioning

confidence: 99%